Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
International Journal of Cancer|March 26, 2013
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17Guranda Chitadze, Marcus Lettau, Jaydeep Bhat, et al.Cancer Research|December 18, 2004
Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acidAlessandro Poggi, Claudia Venturino, Silvia Catellani, et al.International Journal of Cancer|December 18, 2008
Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cellsNicole Schwinn, Daria Vokhminova, Antje Sucker, et al.Oncoimmunology|January 9, 2018
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cellsStefanie Maurer, Korbinian Nepomuk Kropp, Gerd Klein, et al.Cancer Research|July 19, 2005
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproateSorin Armeanu, Michael Bitzer, Ulrich M Lauer, et al.Cancer Research|December 26, 2003
MICA/NKG2D-mediated immunogene therapy of experimental gliomasManuel A Friese, Michael Platten, Stefan Z Lutz, et al.Biochemical and Biophysical Research Communications|April 9, 2008
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidineKai-Fu Tang, Cai-Xia He, Gui-Li Zeng, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteinsMartina Sester, Katja Koebernick, Douglas Owen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2DMathias Krockenberger, Yvonne Dombrowski, Claudia Weidler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100BAnnette Paschen, Antje Sucker, Bettina Hill, et al.Pageof 9